Updates on our COVID-19 Vaccines
Sanofi and GSK announced on May 27 the start of a phase 3 clinical trial for their COVID-19 recombinant vaccine candidate
Sanofi’s Rare Humanitarian Program Turns 30
“Our purpose is clear–to help ensure that people living with rare diseases around the world have the ability to access the treatments they need” -Paul Hudson, Chief Executive Officer
Join us!
You will join a diverse mix of people, who genuinely believe in our mission to help people around the world live healthier lives
-
Press releases2021-09-24MMMM DD YYYYSanofi: Availability of the Q3 2021 Memorandum for modelling purposes